Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lianjun Shen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Diagnostic Cytopathology|October 28, 2021
Prevalence and genotype distribution of high-risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014-2020Qinli Luo, Lin Lang, Na Han, et al.
Neoplasma|December 6, 2023
RNASEH1-AS1 induced by H3K27ac stabilizes ANXA2 mRNA to promote the progression of colorectal cancer through recruiting BUD13Shengwei Zhuang, Weihong Lu, Lianjun Shen, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Functions of inflammatory factor in non-tumor deep venous thrombosis of lower extremity]Xing Sun, Lianjun Shen, Wei Gu, et al.
Blood Advances|April 2, 2026
BCMA/CD19 dual-targeting CAR T cell therapy in older patients with newly diagnosed multiple myeloma: a phase I studyJin Liu, Xiaoqiang Fan, Liying Peng, et al.
Science (New York, N.Y.)|April 18, 2020
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cellsZhiwei Zhou, Huabin He, Kun Wang, et al.
Blood Cancer Journal|July 7, 2022
Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical studyJunfang Yang, Jiaping He, Xian Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2010
TLR4 is a negative regulator in noninfectious lung inflammationHang Zhao, Shaw-Wei Leu, Liyun Shi, et al.
JAMA Oncology|July 25, 2024
B-Cell Maturation Antigen/CD19 Dual-Targeting Immunotherapy in Newly Diagnosed Multiple MyelomaWanting Qiang, Jing Lu, Yanchun Jia, et al.
Cellular & Molecular Immunology|August 12, 2021
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumorsZhenguang Wang, Na Li, Kaichao Feng, et al.
Eclinicalmedicine|January 11, 2024
Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trialYi Luo, Lei Gao, Jia Liu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Diagnostic Cytopathology|October 28, 2021
Prevalence and genotype distribution of high-risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014-2020Qinli Luo, Lin Lang, Na Han, et al.
Neoplasma|December 6, 2023
RNASEH1-AS1 induced by H3K27ac stabilizes ANXA2 mRNA to promote the progression of colorectal cancer through recruiting BUD13Shengwei Zhuang, Weihong Lu, Lianjun Shen, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Functions of inflammatory factor in non-tumor deep venous thrombosis of lower extremity]Xing Sun, Lianjun Shen, Wei Gu, et al.
Blood Advances|April 2, 2026
BCMA/CD19 dual-targeting CAR T cell therapy in older patients with newly diagnosed multiple myeloma: a phase I studyJin Liu, Xiaoqiang Fan, Liying Peng, et al.
Science (New York, N.Y.)|April 18, 2020
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cellsZhiwei Zhou, Huabin He, Kun Wang, et al.
Blood Cancer Journal|July 7, 2022
Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical studyJunfang Yang, Jiaping He, Xian Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2010
TLR4 is a negative regulator in noninfectious lung inflammationHang Zhao, Shaw-Wei Leu, Liyun Shi, et al.
JAMA Oncology|July 25, 2024
B-Cell Maturation Antigen/CD19 Dual-Targeting Immunotherapy in Newly Diagnosed Multiple MyelomaWanting Qiang, Jing Lu, Yanchun Jia, et al.
Cellular & Molecular Immunology|August 12, 2021
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumorsZhenguang Wang, Na Li, Kaichao Feng, et al.
Eclinicalmedicine|January 11, 2024
Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trialYi Luo, Lei Gao, Jia Liu, et al.
Pageof 3